We only have this paper's title and publication details.
Read it at the sourceIbrutinib is associated with higher risk of AF, bleeding, and HF, but not AMI or stroke.
No takes yet. Share an insight, caveat, or question.
Abdel‐Qadir et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: